InvestorsHub Logo
Followers 134
Posts 3749
Boards Moderated 0
Alias Born 01/28/2006

Re: Blues44 post# 172523

Saturday, 02/18/2017 5:08:27 PM

Saturday, February 18, 2017 5:08:27 PM

Post# of 403155
Partnerships plural.
Sounds like the Regeneron model of multiple partners, selective licensing and long term growth is still intact.

"As mentioned by management in previous news releases, a primary focus for the 2017 calendar year is completing work necessary to forge partnerships with larger pharmaceutical companies presently engaged with Cellceutix, some under Confidential Disclosure Agreements (CDAs). Should outcomes from ongoing clinical studies yield favorable results, the Company is optimistic that it will be able to capitalize on the data with respect to a partnership."[color=red][/color]

http://www.cellceutix.com/press-release/2017/2/15/y3616250ilexnq8enkoy8lelciljue

Good luck, Farrell[color=red][/color]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News